EP0923284A4 - Cellular immunogens useful as cancer vaccines - Google Patents

Cellular immunogens useful as cancer vaccines

Info

Publication number: EP0923284A4
Authority: EP; European Patent Office
Prior art keywords: cancer vaccines; immunogens useful; cellular immunogens; cellular; useful
Prior art date: 1996-01-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP97902934A

Other languages

German (de)

French (fr)

Other versions

EP0923284A1 (en

Inventor

Michael S Halpern

James M England

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Drexel University College of Medicine

Original Assignee

Drexel University College of Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-19

Filing date

1997-01-13

Publication date

2003-03-26

1997-01-13 Application filed by Drexel University College of Medicine filed Critical Drexel University College of Medicine

1999-06-23 Publication of EP0923284A1 publication Critical patent/EP0923284A1/en

2003-03-26 Publication of EP0923284A4 publication Critical patent/EP0923284A4/en

Status Withdrawn legal-status Critical Current

Links

229940022399 cancer vaccine Drugs 0.000 title 1
238000009566 cancer vaccine Methods 0.000 title 1
230000001413 cellular effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

EP97902934A 1996-01-19 1997-01-13 Cellular immunogens useful as cancer vaccines Withdrawn EP0923284A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US1026296P	1996-01-19	1996-01-19
US10262P		1996-01-19
PCT/US1997/000582 WO1997025860A1 (en)	1996-01-19	1997-01-13	Cellular immunogens useful as cancer vaccines

Publications (2)

Publication Number	Publication Date
EP0923284A1 EP0923284A1 (en)	1999-06-23
EP0923284A4 true EP0923284A4 (en)	2003-03-26

Family

ID=21744913

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP97902934A Withdrawn EP0923284A4 (en)	1996-01-19	1997-01-13	Cellular immunogens useful as cancer vaccines

Country Status (5)

Country	Link
EP (1)	EP0923284A4 (en)
JP (1)	JP2001501909A (en)
AU (1)	AU717356B2 (en)
CA (1)	CA2241952A1 (en)
WO (1)	WO1997025860A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000004927A1 (en) *	1998-07-24	2000-02-03	Alleghney University Of The Health Sciences	Allogeneic cellular immunogens useful as cancer vaccines
EP1250145A4 (en) *	2000-01-03	2003-03-26	Argonex Pharmaceuticals Inc	C-ski oncogene-derived peptides for prevention, treatment, and diagnosis of cancer
US9068234B2 (en)	2003-01-21	2015-06-30	Ptc Therapeutics, Inc.	Methods and agents for screening for compounds capable of modulating gene expression
US8460864B2 (en)	2003-01-21	2013-06-11	Ptc Therapeutics, Inc.	Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US8426194B2 (en)	2003-01-21	2013-04-23	Ptc Therapeutics, Inc.	Methods and agents for screening for compounds capable of modulating VEGF expression
WO2005049868A1 (en) *	2003-11-17	2005-06-02	Pct Therapeutics, Inc.	Methods and agents for screening for compounds capable of modulating her2 expression
US8283115B1 (en)	2007-06-20	2012-10-09	Ptc Therapeutics, Inc.	Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en)	2007-06-22	2012-10-09	Ptc Therapeutics, Inc.	Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994016737A1 (en) *	1993-01-26	1994-08-04	Weiner David B	Compositions and methods for delivery of genetic material

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5593972A (en) *	1993-01-26	1997-01-14	The Wistar Institute	Genetic immunization

1997
- 1997-01-13 EP EP97902934A patent/EP0923284A4/en not_active Withdrawn
- 1997-01-13 AU AU16992/97A patent/AU717356B2/en not_active Ceased
- 1997-01-13 WO PCT/US1997/000582 patent/WO1997025860A1/en not_active Application Discontinuation
- 1997-01-13 CA CA002241952A patent/CA2241952A1/en not_active Abandoned
- 1997-01-13 JP JP09526124A patent/JP2001501909A/en active Pending

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1994016737A1 (en) *	1993-01-26	1994-08-04	Weiner David B	Compositions and methods for delivery of genetic material

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HALPERN MICHAEL S ET AL: "Endogenous c-src as a determinant of the tumorigenicity of src oncogenes.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 93, no. 2, 23 January 1996 (1996-01-23), 1996, pages 824 - 827, XP002228324, ISSN: 0027-8424 *
JOHNSON P J ET AL: "OVEREXPRESSED PP60C-SRC CAN INDUCE FOCUS FORMATION WITHOUT COMPLETE TRANSFORMATION OF NIH 3T3 CELLS", MOLECULAR AND CELLULAR BIOLOGY, WASHINGTON, DC, US, vol. 5, no. 5, May 1985 (1985-05-01), pages 1073 - 1083, XP009000334, ISSN: 0270-7306 *
See also references of WO9725860A1 *

Also Published As

Publication number	Publication date
WO1997025860A1 (en)	1997-07-24
EP0923284A1 (en)	1999-06-23
JP2001501909A (en)	2001-02-13
AU717356B2 (en)	2000-03-23
CA2241952A1 (en)	1997-07-24
AU1699297A (en)	1997-08-11

Legal Events

Date	Code	Title	Description
1999-05-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1999-06-23	17P	Request for examination filed	Effective date: 19980713
1999-06-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2003-03-26	A4	Supplementary search report drawn up and despatched	Effective date: 20030210
2004-09-08	17Q	First examination report despatched	Effective date: 20040727
2005-06-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-08-10	18D	Application deemed to be withdrawn	Effective date: 20050208

Publication	Publication Date	Title
PL332633A1 (en)	1999-09-27	Vaccines
AU4070097A (en)	1998-03-06	Mucosal immunogens for novel vaccines
GB9812613D0 (en)	1998-08-12	Vaccine
EP0958373A4 (en)	2001-11-28	Vaccines
EP0923284A4 (en)	2003-03-26	Cellular immunogens useful as cancer vaccines
GB9822714D0 (en)	1998-12-09	Vaccines
GB0027072D0 (en)	2000-12-20	Vaccine
GB9620350D0 (en)	1996-11-13	Cancer vaccine
EP1100544A4 (en)	2003-01-15	Allogeneic cellular immunogens useful as cancer vaccines
ZA982763B (en)	1998-10-05	Vaccines
IL132081A0 (en)	2001-03-19	Fibrocyte-based cellular therapy formulations
GB9812316D0 (en)	1998-08-05	Cancer vaccines
GB9806736D0 (en)	1998-05-27	Manufactured cellular vaccine
GB9609252D0 (en)	1996-07-03	Vaccines
GB9807805D0 (en)	1998-06-10	Vaccine
GB9820956D0 (en)	1998-11-18	Vaccine
GB9821821D0 (en)	1998-12-02	Schistomiasis vaccine
GB9727347D0 (en)	1998-02-25	Cancer
GB9604595D0 (en)	1996-05-01	Vaccines
GB9606032D0 (en)	1996-05-22	Vaccines
GB9626882D0 (en)	1997-02-12	Vaccines
GB9614182D0 (en)	1996-09-04	Vaccines
GB9602617D0 (en)	1996-04-10	Vaccines
GB9604596D0 (en)	1996-05-01	Vaccines
GB9605229D0 (en)	1996-05-15	Vaccines